Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC

por Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., der Welle, C. M. Cramer-van, Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., van de Garde, E. M. W.
Publicado 2023